Annals of Nuclear Medicine

Papers
(The TQCC of Annals of Nuclear Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight54
Correction: Novel indices representing heterogeneous distributions of myocardial perfusion imaging34
Conversion from dose length product to effective dose for the CT component of whole-body PET/CT31
A first-in-man study of [18F] FEDAC: a novel PET tracer for the 18-kDa translocator protein29
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?23
[18F]FDG PET/CT is useful in discriminating invasive adenocarcinomas among pure ground-glass nodules: comparison with CT findings—a bicenter retrospective study20
Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis20
Vision-language model performance on the Japanese Nuclear Medicine Board Examination: high accuracy in text but challenges with image interpretation20
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose–positron emission tomography to differentiate between benign and malignant lesions20
18F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study19
Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer’s disease patients19
A first-in-man PET study of 2-amino-[3-11C] isobutyric acid for the amino acid transport System A: biodistribution and dosimetry in healthy volunteers18
Comparison of the diagnostic accuracy of VSBONE BSI versions for detecting bone metastases in breast and prostate carcinoma patients using conventional and CZT detector gamma cameras18
Correction: Practice recommendation for measuring washout rates in 123I-BMIPP fatty acid images17
J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure16
A fully automatic deep learning-based method for segmenting regions of interest and predicting renal function in pediatric dynamic renal scintigraphy16
Correction: Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson’s disease: a Bayesian approach16
Increase of prostate-specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing radium therapy16
PETFormer-SCL: a supervised contrastive learning-guided CNN–transformer hybrid network for Parkinsonism classification from FDG-PET15
Methyl-11C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma14
Prognostic value of pre-treatment metabolic tumor volume on [S‑methyl‑11C]‑L‑methionine PET/CT in patients with local non-small cell lung carcinoma treated with single-fraction carbon-ion radiotherapy14
Efficacy of [68Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis14
Feasibility of whole-body 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography angiography using continuous bed motion in patients with vascular disease: a pilot study13
Incidence of renal scarring on technetium-99 m dimercaptosuccinic acid renal scintigraphy after acute pyelonephritis, acute focal bacterial nephritis, and renal abscess13
Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer13
Impact of irregular waveforms on data-driven respiratory gated PET/CT images processed using MotionFree algorithm13
The value of 18F-FDG PET/CT in Langerhans cell histiocytosis13
Insights into lung cancer diagnosis and clinical management using [18F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT)12
Can interactive artificial intelligence be used for patient explanations of nuclear medicine examinations in Japanese?12
Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine12
Prediction of multivessel coronary artery disease and candidates for stress-only imaging using multivariable models with myocardial perfusion imaging12
Increased individual workload for nuclear medicine physicians over the past years: 2008–2023 data from The Netherlands12
Novel indices representing heterogeneous distributions of myocardial perfusion imaging12
Diagnostic value of FDG PET/CT in determining the etiology of pericardial effusion12
Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor 11C-methionine PET/CT imaging11
Comparison of transient and permanent LAD ligation in mice using 18F-FDG PET imaging11
Recent advancements in new tracers from first-in-human studies11
Effect of previous 177Lu-DOTATATE treatment on 90Y-microsphere treatment response in neuroendocrine tumor patients with liver metastasis11
Diagnostic value of 18F-FDG PET/CT in the follow-up of conjunctival melanoma11
Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI10
Factors predicting remission in hyperthyroid patients after low-dose I-131 therapy: 20 years retrospective study from a tertiary care hospital10
Correction: Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment uti10
Is there any effect of hcc location on selective internal radiation therapy with 90yttrium response?10
Current status and perspectives of nuclear cardiology10
SPECT reconstruction using preprocessing masking for extra-cardiac uptake versus standard processing in 99mTc-sestamibi myocardial perfusion imaging10
Improvement in the estimation of perfusable tissue fraction and myocardial flow reserve in the ischemic myocardial lesions using ECG-gated dynamic myocardial PET with 15O-water10
Multimodal imaging analysis of autosomal recessive Parkinson’s disease10
Correction to: Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [123I]FP-CIT SPECT images10
A Monte Carlo study comparing dead-time losses of a gamma camera between tungsten functional paper and lead sheet for dosimetry in targeted radionuclide therapy with Lu-1779
Brain imaging of sequential acquisition using a flexible PET scanner and 3-T MRI: quantitative and qualitative assessment9
Temporal metabolic response and mRNA COVID-19 vaccination9
Assessment of post-pyeloplasty renal drainage in antenatally detected hydronephrosis by 99mTc-L, L-Ethylenedicysteine renal scintigraphy: the importance of delayed imaging9
[99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor9
Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoi9
Correction to: Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study9
Performance evaluation of dedicated brain PET scanner with motion correction system9
Impact of preoperative [18F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study9
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography9
Detection of apoptosis by [18F]ML-10 after cardiac ischemia–reperfusion injury in mice9
Validation of advanced hybrid SPECT/CT system using dynamic anthropomorphic cardiac phantom9
Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands8
New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map8
Next day sentinel node biopsy for melanoma after lymphoscintigraphy using 99mTc-labelled nanocolloid does not adversely affect long-term outcomes8
The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer8
Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis8
Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects8
Feasibility of position emission tomography derived endocardial wall strain: direct comparison with magnetic resonance using hybrid 13N ammonia PETMR system8
Superiority of 68Ga-PSMA-11 PET/CT over mpMRI for lateralization accuracy of diagnosing intra-glandular prostate cancer lesions: avoiding fluke targeting8
Manual on the proper use of meta-[211At] astato-benzylguanidine ([211At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)8
Booster administration of Tc-99m PMT for delayed static imaging in patients with biliary atresia8
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients8
Are [18F]FDG PET/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?8
Inferences of SPECT renal dynamic imaging injection quality based on lung and abdominal aorta imaging features8
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma7
Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up7
Comparative evaluation of radionuclide therapy using 90Y and 177Lu7
Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using 18F-FDG PET7
Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects7
99mTc-labeled peptide targeting interleukin 13 receptor α 2 for tumor imaging in a cervical cancer mouse model6
Advances in the molecular imaging of primary aldosteronism6
Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer6
Artificial neural network for the prediction model of glomerular filtration rate to estimate the normal or abnormal stages of kidney using gamma camera6
The quest for multifunctional and dedicated PET instrumentation with irregular geometries6
Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer6
Development of lung cancer risk prediction models based on F-18 FDG PET images6
Radiolabeled florescent-magnetic graphene oxide nanosheets: probing the biodistribution of a potential PET-MRI hybrid imaging agent for detection of fibrosarcoma tumor6
Application of artificial intelligence in brain molecular imaging6
Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis6
Physiological bio-distribution of 68Ga-DOTA-TATE in pediatric patients6
Clinical value of 18F-FDG PET/CT in IgG4-related disease6
18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment6
A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy6
Differentiating second primary lung cancer from pulmonary metastasis in patients of single solitary pulmonary lesion with extrapulmonary tumor using multiparametric analysis of FDG PET/CT6
Performance of dedicated breast PET in breast cancer screening: comparison with digital mammography plus digital breast tomosynthesis and ultrasound6
Blood and bone marrow dosimetry for thyroid cancer patients prepared with rhTSH injection6
Investigation on low-iodine diet implementation by medical staff before radioactive iodine treatment for differentiated thyroid carcinoma6
SPECT/CT imaging: quantifying 99mTc-MDP concentration in the spine and pelvis5
New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT5
Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study5
Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis5
Pre-treatment 111In-pentetreotide SPECT/CT vs. baseline 177Lu-DOTATATE SPECT/CT: are there differences in lesion uptake and detectability?5
Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment5
The role of dual-tracer PET imaging with ER and HER2 in patients with metastatic breast cancer: a pilot study5
Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study5
68Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients5
Correlation between the thyroid computed tomography value and thyroid function in hyperthyroidism: a retrospective study5
Validation of quantitative [18F]NaF PET uptake parameters in bone diseases: a systematic review5
Use of dose–volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres5
Pharmacokinetics and dosimetry of [177Lu]Lu-PSMA-617 and [68Ga]Ga-PSMA-11 in Japanese patients with PSMA-positive mCRPC5
Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer5
0.14388704299927